# Novel Point-of-Care Diagnostic Test for SARS-CoV-2 (COVID-19)

> **NCT04513990** · NA · UNKNOWN · sponsor: **M.D. Anderson Cancer Center** · enrollment: 257 (actual)

## Conditions studied

- COVID-19 Infection

## Interventions

- **PROCEDURE:** Biospecimen Collection
- **OTHER:** Questionnaire Administration

## Key facts

- **NCT ID:** NCT04513990
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-04-09
- **Primary completion:** 2023-04-30
- **Final completion:** 2023-04-30
- **Target enrollment:** 257 (ACTUAL)
- **Last updated:** 2021-12-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04513990

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04513990, "Novel Point-of-Care Diagnostic Test for SARS-CoV-2 (COVID-19)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04513990. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*